DENVER, September 17, 2024--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR) ("Palantir"), and Nebraska Medicine, a $2.5B academic health system based in Omaha, and a national leader in healthcare innovation, today announced a new multi-year, multi-million-dollar contract for Palantir’s Artificial Intelligence Platform (AIP) to help improve healthcare through transformational technologies.

Nebraska Medicine invests in driving innovation at a rate that most peers would deem impossible. Less than one year into the partnership, Nebraska Medicine has implemented more than ten applications of AIP, improving patient throughput, expanding claims reimbursements, and better monitoring patient care. AIP provides Nebraska Medicine safe and secure awareness of their operations, with long-term opportunities for transformation across Nebraska Medicine’s enterprise, and more.

Palantir and Nebraska Medicine started working together in January 2024, sharing a mission to rapidly solve critical healthcare problems. The proof: Nebraska Medicine represents Palantir’s fastest time to enterprise commitment of any Palantir health system partner to-date. In a series of targeted bootcamps, Nebraska Medicine took less than 6 weeks to put a new workflow in production and as little as 90 minutes to introduce more. Since partnering with Palantir, Nebraska Medicine has seen a +2000% increase in Discharge Lounge utilization, freeing up beds earlier for patients and decreasing time from discharge order to patient discharge by one hour on average. Furthermore, Nebraska Medicine sent 1,200+ AI-powered appeal letters to payors in less than 3 months, helping the health system more efficiently and effectively respond to claims denials, leveraging AI to combat payor behaviors. The areas of focus vary wider: Nebraska Medicine uses AIP to predict OR and PACU bed necessity, manage their supply chain, recommend staff movements, and more.

"Nebraska Medicine is one of the most innovative healthcare organizations in the country. While many organizations talk about having bold visions, Nebraska Medicine takes actions to translate ideas into real solutions, quickly," said Drew Goldstein, Co-Head of Healthcare at Palantir. "Their swift commitment to this enterprise partnership highlights our shared focus on rapidly delivering value and driving impactful outcomes to enhance patient care."

"Our partnership with Palantir is delivering real results for our patients and our staff," said Michael Ash, MD, Nebraska Medicine president and chief operating officer. "The technology allows our staff to work smarter, and for more of our patients to leave the hospital as soon as they’re able. Most exciting for us – this is just the beginning of the innovations we’ll discover together and lead the way for other hospitals."